Highlights from the International Congress of Parkinson’s Disease and Movement Disorders 2024

Posted on by Rebecca Gilbert, MD, Ph.D.

Read about research updates presented at MDS 2024 Every year, the International Parkinson and Movement Disorder Society (MDS) holds...see more its International Congress of Parkinson’s Disease and Movement Disorders (also known as the MDS Congress), which is the preeminent gathering of medical professionals from around the world who are dedicated to researching and treating Parkinson’s disease […]

Read More

2023 Update: New Parkinson’s Disease Treatments in the Clinical Trial Pipeline

Posted on by Rebecca Gilbert, MD, Ph.D.

New Parkinson’s Medication on the Horizon The development of potential new medications for Parkinson’s disease (PD) medications remains very...see more active, with multiple new medications in various stages of research development that are aiming to treat and slow down PD. In past blogs, we have reviewed the various mechanisms of action that are being studied to […]

Read More

Therapies for non-motor symptoms of Parkinson’s disease in clinical trials

Posted on by Rebecca Gilbert, MD, Ph.D.

The pipeline for Parkinson’s disease (PD) medications is extremely crowded these days, with multiple medications at various stages of...see more research and development. Currently most of the approved medications for PD address the motor symptoms of PD – tremor, slowness, stiffness, and walking difficulties. Medications are also available to help people overcome OFF time or improve […]

Read More